$TVTX SEC Filings

Filed On	Filing
19 Oct 2026	Form 4: Dube Eric M, Director Received 243,735 shares by exercise or conversion ($2.96M) · Sold 243,735 shares ($13.1M)
15 Oct 2026	144
21 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers THIS EMPLOYMENT AGREEMENT is entered into by and between Travere Therapeutics, Inc., a Delaware corporation (hereinafter the “Company”), and Bradley Campbell (hereinafter “Executive”).
17 Sep 2026	144
17 Sep 2026	144
17 Sep 2026	Form 4: Cline Christopher R., CHIEF FINANCIAL OFFICER Received 20,000 shares by exercise or conversion ($349K) · Sold 50,508 shares ($3.15M)
17 Sep 2026	Form 4: Inrig Jula, EVP, Head of R&D & CMO Received 32,395 shares by exercise or conversion ($289K) · Sold 44,674 shares ($2.79M)
17 Sep 2026	Form 4: Calvin Sandra, SVP, CHIEF ACCOUNTING OFFICER Received 5,375 shares by exercise or conversion ($130K) · Sold 5,375 shares ($335K)
17 Sep 2026	Form 4: Heerma Peter, EVP, CHIEF COMMERCIAL OFFICER Received 77,190 shares by exercise or conversion ($1.41M) · Sold 102,190 shares ($6.36M) · Received 172,717 shares by exercise or conversion ($2.45M) · 3 more
17 Sep 2026	Form 4: Dube Eric M, Director Received 95,666 shares by exercise or conversion ($2.23M) · Sold 95,666 shares ($5.96M) · Received 195,841 shares by exercise or conversion ($4.57M) · 3 more
17 Sep 2026	Form 4: Rote William E., Chief Research Officer Received 78,650 shares by exercise or conversion ($1.7M) · Sold 96,198 shares ($5.99M) · Received 112,850 shares by exercise or conversion ($2.4M) · 1 more
17 Sep 2026	Form 4: Reed Elizabeth E, Chief Legal Officer and GC Received 37,500 shares by exercise or conversion ($580K) · Sold 37,500 shares ($2.34M)
16 Sep 2026	144
16 Sep 2026	144
16 Sep 2026	144
15 Sep 2026	144
15 Sep 2026	144
15 Sep 2026	144
15 Sep 2026	144
15 Sep 2026	144

Comments